Assistant Professor of Nursing, the University of Virginia School of Nursing, Charlottesville, VA.
Licensed Clinical Research Coordinator, the University of Virginia School of Nursing, Charlottesville, VA.
Nephrol Nurs J. 2022 May-Jun;49(3):265-271.
Routine screening of cognitive function in patients with end stage kidney disease (ESKD) is recommended, yet rarely it happens. This study sought to identify barriers to cognitive function screening for patients with ESKD receiving in-center hemodialysis. To ascertain their perceptions of cognitive function screening, 100 patients aged 50 years and older (48% female, 49% Black/African-American) from seven hemodialysis centers participated in structured interviews after completing the Montreal Cognitive Assessment and Geriatric Depression Scale. Participants rated the screening experience favorably, indicating cognitive function screening is acceptable to patients receiving hemodialysis. The level of cognitive impairment was the only factor significantly associated with screening evaluation scores, with participants with scores indicating mild or moderate impairment evaluating screening less favorably than those with normal cognitive function scores. Next steps include identifying systems level barriers and establishing appropriate follow up for patients with abnormal screening results.
建议对终末期肾病（ESKD）患者进行认知功能的常规筛查，但很少有医院这样做。本研究旨在确定接受中心血液透析的 ESKD 患者认知功能筛查的障碍。为了确定他们对认知功能筛查的看法，来自七个血液透析中心的 100 名年龄在 50 岁及以上的患者（48%为女性，49%为黑人/非裔美国人）在完成蒙特利尔认知评估和老年抑郁量表后参加了结构化访谈。参与者对筛查体验评价良好，表明血液透析患者接受认知功能筛查是可以接受的。认知障碍的程度是唯一与筛查评估得分显著相关的因素，与认知功能正常得分的参与者相比，得分表明存在轻度或中度障碍的参与者对筛查的评价较差。下一步包括确定系统层面的障碍，并为筛查结果异常的患者建立适当的随访。
